Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 383

    1.

    Low plasma adiponectin levels are associated with increased hepatic lipase activity in vivo.

    Schneider JG, von Eynatten M, Schiekofer S, Nawroth PP, Dugi KA.

    Diabetes Care. 2005 Sep;28(9):2181-6.PMID: 16123487 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Decreased plasma lipoprotein lipase in hypoadiponectinemia: an association independent of systemic inflammation and insulin resistance.

    von Eynatten M, Schneider JG, Humpert PM, Rudofsky G, Schmidt N, Barosch P, Hamann A, Morcos M, Kreuzer J, Bierhaus A, Nawroth PP, Dugi KA.

    Diabetes Care. 2004 Dec;27(12):2925-9.PMID: 15562208 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Association between hypoadiponectinemia and cardiovascular risk factors in nonobese healthy adults.

    Im JA, Kim SH, Lee JW, Shim JY, Lee HR, Lee DC.

    Metabolism. 2006 Nov;55(11):1546-50.PMID: 17046559 [PubMed - indexed for MEDLINE]Related articles

    4.

    Correlation between the adiponectin-leptin ratio and parameters of insulin resistance in patients with type 2 diabetes.

    Inoue M, Maehata E, Yano M, Taniyama M, Suzuki S.

    Metabolism. 2005 Mar;54(3):281-6.PMID: 15736103 [PubMed - indexed for MEDLINE]Related articles

    5.

    Circulating adiponectin levels are associated with better glycemic control, more favorable lipid profile, and reduced inflammation in women with type 2 diabetes.

    Mantzoros CS, Li T, Manson JE, Meigs JB, Hu FB.

    J Clin Endocrinol Metab. 2005 Aug;90(8):4542-8. Epub 2005 May 24.PMID: 15914524 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Post-heparin plasma lipoprotein lipase, but not hepatic lipase activity, is related to plasma adiponectin in type 2 diabetic patients and healthy subjects.

    De Vries R, Wolffenbuttel BH, Sluiter WJ, van Tol A, Dullaart RP.

    Clin Lab. 2005;51(7-8):403-9.PMID: 16122151 [PubMed - indexed for MEDLINE]Related articles

    7.

    Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes.

    Shetty GK, Economides PA, Horton ES, Mantzoros CS, Veves A.

    Diabetes Care. 2004 Oct;27(10):2450-7.PMID: 15451915 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Variability in postheparin hepatic lipase activity is associated with plasma adiponectin levels in African Americans.

    Clarenbach JJ, Vega GL, Adams-Huet B, Considine RV, Ricks M, Sumner AE.

    J Investig Med. 2007 May;55(4):187-94.PMID: 17651673 [PubMed - indexed for MEDLINE]Related articles

    9.

    Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity.

    Bugianesi E, Pagotto U, Manini R, Vanni E, Gastaldelli A, de Iasio R, Gentilcore E, Natale S, Cassader M, Rizzetto M, Pasquali R, Marchesini G.

    J Clin Endocrinol Metab. 2005 Jun;90(6):3498-504. Epub 2005 Mar 29.PMID: 15797948 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Combination of C-reactive protein and high molecular weight (HMW)-adiponectin reflects further metabolic abnormalities compared with each of them alone in Japanese type 2 diabetic subjects.

    Saisho Y, Hirose H, Yamamoto Y, Nakatani H, Itoh H.

    Endocr J. 2008 May;55(2):331-8. Epub 2008 Mar 25.PMID: 18362454 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Circulating osteoprotegerin is correlated with lipid profile, insulin sensitivity, adiponectin and sex steroids in an ageing male population.

    Gannagé-Yared MH, Fares F, Semaan M, Khalife S, Jambart S.

    Clin Endocrinol (Oxf). 2006 Jun;64(6):652-8.PMID: 16712667 [PubMed - indexed for MEDLINE]Related articles

    12.

    Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism.

    Tschritter O, Fritsche A, Thamer C, Haap M, Shirkavand F, Rahe S, Staiger H, Maerker E, Häring H, Stumvoll M.

    Diabetes. 2003 Feb;52(2):239-43.PMID: 12540592 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Inflammation, insulin resistance, and adiposity: a study of first-degree relatives of type 2 diabetic subjects.

    Kriketos AD, Greenfield JR, Peake PW, Furler SM, Denyer GS, Charlesworth JA, Campbell LV.

    Diabetes Care. 2004 Aug;27(8):2033-40.PMID: 15277436 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.

    González AI, Schreier L, Elbert A, Berg G, Beresan H, López G, Wikinski R.

    Metabolism. 2003 Jan;52(1):116-21.PMID: 12524671 [PubMed - indexed for MEDLINE]Related articles

    15.
    16.

    Reciprocal association between visceral obesity and adiponectin: in healthy premenopausal women.

    Kwon K, Jung SH, Choi C, Park SH.

    Int J Cardiol. 2005 Jun 8;101(3):385-90.PMID: 15907405 [PubMed - indexed for MEDLINE]Related articles

    17.

    Low plasma apelin levels in newly diagnosed type 2 diabetes mellitus.

    Erdem G, Dogru T, Tasci I, Sonmez A, Tapan S.

    Exp Clin Endocrinol Diabetes. 2008 May;116(5):289-92.PMID: 18484561 [PubMed - indexed for MEDLINE]Related articles

    19.

    High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus.

    Dullaart RP, de Vries R, Sluiter WJ, Voorbij HA.

    Clin Endocrinol (Oxf). 2009 Feb;70(2):221-6.PMID: 18505467 [PubMed - indexed for MEDLINE]Related articles

    20.

    Relationship between adiponectin and metabolic variables in Caribbean offspring of patients with type 2 diabetes mellitus.

    Ezenwaka CE, Kalloo R, Uhlig M, Eckel J.

    Horm Metab Res. 2004 Apr;36(4):238-42.PMID: 15114523 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data